-Livemint.com The nine-member cotton seed price control committee has recommended a maximum sale price of Rs.800 for a 450g packet of Bollgard II Bt cotton seeds New Delhi: A government panel on genetically modified Bt cotton has recommended a steep reduction in royalty fees payable to technology companies, and lower seed prices. If accepted, the recommendations will benefit nearly 8 million cotton farmers in India, but may raise concerns about how India...
More »SEARCH RESULT
Total Matching Records found : 184
Drug pricing: a bitter pill to swallow -Feroze Varun Gandhi
-The Hindu Medicines remain overpriced and unaffordable in India. In a country mired in poverty, medical debt remains the second biggest factor for keeping millions in poverty. The international pharmaceutical industry has found its cash cow in India’s beleaguered consumers. With a minimum wage of Rs.250/day for a government worker, a basic wage worker afflicted with a chronic disease like multi-drug-resistant tuberculosis faces penury. His treatment, with drug combinations, which works out...
More »Govt to sell 439 key drugs at low prices -Sushmi Dey
-The Times of India NEW DELHI: The government is set to expand the coverage of its Jan Aushadhi scheme. It will offer 439 life-saving medicines, including cancer and cardiovascular drugs, as well as 250 medical devices like stents and implants at 40-50% discounted prices. The department of Pharmaceuticals plans to open 300 Jan Aushadhi stores across the country by March and another 3,000 by 2017. Presently, only 45 medicines are available in...
More »Scientifically validated Rs 5 anti-diabetes herbal drug launched by CSIR -Neha Shukla
-The Times of India LUCKNOW: A scientifically validated anti-diabetes herbal drug, named 'BGR-34', was launched by a Council of Scientific and Industrial Research (CSIR) lab in Lucknow on Sunday. A combination of natural extracts from plants, the drug is based on Ayurveda and has no side effects. The drug is for management of type-II diabetes mellitus. The drug has been jointly developed by two CSIR laboratories, National Botanical Research Institute (NBRI) and...
More »Pharma companies may be fined for freebies to doctors -Sushmi Dey
-The Times of India NEW DELHI: Pharma companies may have to cough up huge penalties for unethical and illegal practices like offering freebies, gifts and foreign trips to doctors for pushing the sales of their products. The government is set to make mandatory the uniform code of conduct for pharmaceutical marketing practices, which have so far been voluntary. The department of Pharmaceuticals (DoP) is working on a draft which will curb unethical...
More »
